136 related articles for article (PubMed ID: 115504)
21. [Isolation and properties of a highly purified Clostridium botulinum type F toxin].
Uvarova RN; Reshetnikova LN; Ispolatovskaia MV; Bulatova TI
Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):42-6. PubMed ID: 7004005
[TBL] [Abstract][Full Text] [Related]
22. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes].
Ozegowski JH; Knöll H; Gerlach D; Köhler W
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714
[TBL] [Abstract][Full Text] [Related]
23. [Soluble proteins of the vegetative cells and spores of Clostridium botulinum type B and their toxicity].
Nikolaeva SA
Prikl Biokhim Mikrobiol; 1976; 12(3):449-53. PubMed ID: 792871
[TBL] [Abstract][Full Text] [Related]
24. [Extraction and concentration of Clostridium botulinum toxins from specimens (author's transl)].
Sonnenschein B; Bisping W
Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):247-59. PubMed ID: 5836
[TBL] [Abstract][Full Text] [Related]
25. Purification and crystallization of Clostridium botulinum type C toxin.
Syuto B; Kubo S
Jpn J Vet Res; 1972 Jun; 20(1):19-30. PubMed ID: 4628910
[No Abstract] [Full Text] [Related]
26. Purification and characterization of two components of botulinum C2 toxin.
Ohishi I; Iwasaki M; Sakaguchi G
Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
[TBL] [Abstract][Full Text] [Related]
27. Structure of the outer membrane and toxin localization of Clostridium botulinum type E [proceedings].
Ohyama A; Yabuuchi E; Ito T; Tanimura E; Yamamoto N
Jpn J Med Sci Biol; 1978 Apr; 31(2):170-2. PubMed ID: 355685
[No Abstract] [Full Text] [Related]
28. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
[TBL] [Abstract][Full Text] [Related]
29. [Preparation and properties of the staphylococcal toxin causing the toxic shock syndrome].
Fan'kovskaia MK; Ezepchuk IuV; Solov'eva MN; Shcheglovitova ON
Mol Gen Mikrobiol Virusol; 1987 Jul; (7):23-7. PubMed ID: 3670320
[TBL] [Abstract][Full Text] [Related]
30. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
Ivanova LG; Sergeeva TI
Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
[No Abstract] [Full Text] [Related]
31. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
Oguma K; Syuto B; Iida H; Kubo S
Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
[TBL] [Abstract][Full Text] [Related]
32. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
Kozaki S; Sakaguchi S; Sakaguchi G
Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
[TBL] [Abstract][Full Text] [Related]
33. Simplified purification method for Clostridium botulinum type E toxin.
Giménez JA; Sugiyama H
Appl Environ Microbiol; 1987 Dec; 53(12):2827-30. PubMed ID: 3435146
[TBL] [Abstract][Full Text] [Related]
34. Isolation and molecular size of Clostridium botulinum type C toxin.
Syuto B; Kubo S
Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
[TBL] [Abstract][Full Text] [Related]
35. Purification and amino acid composition of type A botulinum neurotoxin.
DasGupta BR; Sathyamoorthy V
Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of Clostridium botulinum type E from soil of Gwalior, India.
Dhaked RK; Sharma SK; Parida MM; Singh L
J Nat Toxins; 2002 Feb; 11(1):49-56. PubMed ID: 11829060
[TBL] [Abstract][Full Text] [Related]
37. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
DasGupta BR
J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
[TBL] [Abstract][Full Text] [Related]
38. PURIFICATION AND MOLECULAR WEIGHT DETERMINATION OF CLOSTRIDIUM BOTULINUM TYPE E TOXIN.
GERWING J; DOLMAN CE; REICHMANN ME; BAINS HS
J Bacteriol; 1964 Jul; 88(1):216-9. PubMed ID: 14197891
[TBL] [Abstract][Full Text] [Related]
39. ISOLATION AND CHARACTERIZATION OF A TOXIC MOIETY OF LOW MOLECULAR WEIGHT FROM CLOSTRIDIUM BOTULINUM TYPE A.
GERWING J; DOLMAN CE; BAINS HS
J Bacteriol; 1965 May; 89(5):1383-6. PubMed ID: 14293025
[TBL] [Abstract][Full Text] [Related]
40. Molecular construction of Clostridium botulinum type A toxins.
Sugii S; Sakaguchi G
Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
